According to the research report titled ‘Global Ibuprofen API Market size study by Application (Headache, Arthritis, Others), by End-User (CROs and CMOs, Pharmaceutical and Biopharmaceutical Company), Regional Forecasts 2021-2027’, available with MarketStudyReport, global ibuprofen API market is expected to grow at a CAGR of 4.8% during the forecast period 2021-2027.
 

Rising incidence of chronic diseases, as well as an increase in pharmaceutical & biopharmaceutical production, are the primary factors propelling the growth of global ibuprofen API market. 
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4219642/
 

For the unversed, ibuprofen is a medication in the anti-inflammatory drug class that facilitates the reduction of hormones in the body that cause pain and inflammation. It is used to treat a variety of conditions, including menstrual discomfort, back pain, toothaches, headaches, and fever.
 

Increasing proportion of geriatric population, which is more susceptible to illnesses and health conditions is further accelerating the industry expansion. Moreover, increasing incidence of conditions such as rheumatoid arthritis across several countries is also expected to contribute significantly to market expansion in the upcoming years.
 

Despite the positive outlook, surging production costs of this drug are likely to impede market growth in the forthcoming years.
 

Based on application spectrum, worldwide ibuprofen API industry is categorized into arthritis, headaches, and others. In terms of end user scope, the market is classified into CROs & CMOs, and pharmaceutical & biopharmaceutical companies. 
 

From a regional standpoint, Asia-Pacific market is projected to expand rapidly over the forecast period, owing to increased healthcare spending in the region. Moreover, low cost of production, particularly in developing economies such as China and India has resulted in the onset of many manufacturing facilities inviting pharmaceutical and biotechnology companies from around the world to the Asia-Pacific region, thereby augmenting regional industry development.
 

The competitive landscape of global ibuprofen API market is defined by companies such as Hubei Biocause Pharmaceutical Co., Ltd., IOL Chemicals & Pharmaceuticals Ltd., Perrigo Company plc, Alveda Pharmaceuticals Inc., Reckitt Benckiser Group plc, Xinhua Pharmaceutical (Gaomi) Co., Ltd., BASF SE, Solara Active Pharma Sciences Ltd., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and SI Group, Inc. among others.